Abstract:Objective To compare the effects of blood pressure control and the expense of antihypertensive drugs among patients using different treatment methods .Methods Between September to December in 2013, we enrolled 79 patients who were under the administration of community follow -up management on hypertension but received treatment and obtained antihypertensive drugs in the secondary or tertiary hospitals as non -community treatment group.By 1:1 match in the aspects of gender, age, BMI, education level, course of disease, risk stratification, working condition and medical expense , we included 79 patients who were under the administration of community follow -up management on hypertension and received treatment and obtained antihypertensive drugs in community health service settings as community treatment group .PHQ-9 was adopted to conduct assessment on these patients .Patients′awareness rate of risk factors for hypertension , compliance to drug administration and blood pressure control rate were investigated as the indexes of blood pressure control effect ; the number of visits to doctors, the total medical expense for hypertension treatment , the expense covered by medical insurance , self -paid expense, monthly expense for antihypertensive drugs , expense per time and categories of antihypertensive drugs in the past 6 months were collected.Results The two groups were not significantly different in PHQ-9 score ( P>0.05) .The two groups were not significantly different in patients′awareness rate of risk factors for hypertension ( P>0.05 ) , and the two groups were significantly different in the rate of compliance to drug administration and blood pressure control rate (P<0.05) .The two groups were not significantly different in the number of visits to doctors (P>0.05), and the two group were significantly different in the total medical expenses for hypertension treatment , the expense covered by medical insurance , self -paid expense , monthly expense for antihypertensive drugs and expense per time ( P<0.05 ) .The two groups were significantly different in the usage rates of calcium antagonists and Zhenjujiangya tablets ( P <0.05 ) , and the two groups were not significantly different in diuretics, β-receptor blocker, angiotensin converting enzyme inhibitor , angiotensinⅡreceptor blocker and compound reserpine ( P>0.05 ) .Conclusion Patients who are treated in community health service settings have superior compliance to drug administration, higher blood pressure control rate and lower medical expense than patients who are treated in non -community medical settings.

Comparison of Beijing Anti-hypertension 0 and Amlodiping in Treatment Essential Hypertension

Long-term Efficacy and Safety of Beijing Hypotensive No.0 in Patients with Mild to Moderate Essential Hypertension

Study on the long-term efficacy and safety of medicine named 'Beijing Hypertensive No. 0' in patients with primary hypertension]

Effects of Atenolol and Diltiazem-Sr on Quality of Life in the Hypertensive Patients

Efficacy and Safety of Olmesartan Medoxomil-Amlodipine Besylate Tablet in Chinese Patients with Essential Hypertension: A Prospective, Single-Arm, Multi-Center, Real-World Study

Current Status of Morning Blood Pressure Control and Medication of Hypertensive Patients in Beijing

The Effectiveness and Safety of L-amlodipine Besylate for Blood Pressure Control in Patients with Mild to Moderate Essential Hypertension

Comparison of two single-pill dual combination antihypertensive therapies in Chinese patients: a randomized, controlled trial

A5504 Comparison of the Effects of Valsartan and Amlodipine on the Characteristics of Ambulatory Blood Pressure in Hypertensive Patients

Effects of Amlodipine Plus Telmisartan or Amlodipine Plus Amiroride Regimen on Blood Pressure Control in Hypertensive Patients:Preliminary Report of Chinese Hypertension Intervention Efficacy (Chief)trial

Effect of levamlodipine besylate on vascular function in patients with mild-to-moderate hypertension

Compound anti-hypertensive tablets (No.0) for primary hypertension:a systematic review

Efficacy and safety of aranidipine enteric-coated tablets compared with amlodipine in Chinese patients with mild to moderate essential hypertension: a multicenter, randomized, double-blind, parallel-controlled clinical trial.

PS 14-31 AMBULATORY BLOOD PRESSURE LOWERING EFFICACY AND TOLERABILITY OF INITIAL HIGH DOSE OF AMLODIPINE IN MILD OR MODERATE HYPERTENSION

Effects and Expense of Blood Pressure Control on Hypertensive Patients Using Different Treatment Methods: A Comparative Study

Multicenter clinical trial on benidipine in the treatment of hypertension

A randomized controlled trial of arotinolol and amlodipine in diabetes patients with hypertension

Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China.

[PP.22.24] THE NEW CONTRASTING TRIAL AMONG BIOFEEDBACK OR TRADITIONAL CHINESE MEDICINE OF TIANMA GOUTENG DECOCTION AND L AMLODIPINE BESYLATE IN PATIENTS WITH ESSENTIAL HYPERTENSION

The Effects of Compound Antihypertensive Tablets No.0 (HTDR) on Serum Potassium, Serum Sodium and Uric Acid in Hypertension Patients in Community

The Comparative Study for The Clinical Treatment Effect of Different Treatment Methods in the Treatment of Hypertensive Patients with Coronary Heart Disease